GSK shares have risen 44p to 1476p after it reiterated full-year guidance and said it is “well positioned” to cope with the impact of any changes to US tariff rules. The reassurance came as GSK ...

It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality ...